Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
33569 | 89 | 38.2 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
222 | 19941 | LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ENDOSIALIN | Author keyword | 52 | 87% | 29% | 26 |
2 | CD248 | Author keyword | 17 | 79% | 12% | 11 |
3 | TEM1 | Author keyword | 9 | 67% | 9% | 8 |
4 | TNFRSF21 | Author keyword | 2 | 67% | 2% | 2 |
5 | TUMOR ENDOTHELIAL MARKERS | Author keyword | 2 | 67% | 2% | 2 |
6 | BIOBODY | Author keyword | 1 | 50% | 2% | 2 |
7 | TUMOR ENDOTHELIAL MARKER 1 | Author keyword | 1 | 100% | 2% | 2 |
8 | TUMOR ENDOTHELIAL MARKER | Author keyword | 1 | 33% | 2% | 2 |
9 | DR6 | Author keyword | 1 | 23% | 3% | 3 |
10 | BIOMED RHEUMATOL GRP | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ENDOSIALIN | 52 | 87% | 29% | 26 | Search ENDOSIALIN | Search ENDOSIALIN |
2 | CD248 | 17 | 79% | 12% | 11 | Search CD248 | Search CD248 |
3 | TEM1 | 9 | 67% | 9% | 8 | Search TEM1 | Search TEM1 |
4 | TNFRSF21 | 2 | 67% | 2% | 2 | Search TNFRSF21 | Search TNFRSF21 |
5 | TUMOR ENDOTHELIAL MARKERS | 2 | 67% | 2% | 2 | Search TUMOR+ENDOTHELIAL+MARKERS | Search TUMOR+ENDOTHELIAL+MARKERS |
6 | BIOBODY | 1 | 50% | 2% | 2 | Search BIOBODY | Search BIOBODY |
7 | TUMOR ENDOTHELIAL MARKER 1 | 1 | 100% | 2% | 2 | Search TUMOR+ENDOTHELIAL+MARKER+1 | Search TUMOR+ENDOTHELIAL+MARKER+1 |
8 | TUMOR ENDOTHELIAL MARKER | 1 | 33% | 2% | 2 | Search TUMOR+ENDOTHELIAL+MARKER | Search TUMOR+ENDOTHELIAL+MARKER |
9 | DR6 | 1 | 23% | 3% | 3 | Search DR6 | Search DR6 |
10 | CLEC14A | 1 | 50% | 1% | 1 | Search CLEC14A | Search CLEC14A |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TUMOR ENDOTHELIAL MARKER 1 | 20 | 100% | 10% | 9 |
2 | TUMOR ENDOTHELIAL MARKER 1 TEM1 | 14 | 100% | 8% | 7 |
3 | ENDOSIALIN TEM1 | 11 | 67% | 11% | 10 |
4 | ENDOSIALIN | 9 | 64% | 10% | 9 |
5 | TUMOR ENDOTHELIUM | 5 | 27% | 17% | 15 |
6 | TEM1 | 4 | 40% | 9% | 8 |
7 | ENDOTHELIAL MARKERS | 2 | 24% | 7% | 6 |
8 | DR6 | 1 | 33% | 2% | 2 |
9 | LINE EWING TUMOR | 1 | 50% | 1% | 1 |
10 | MOLECULAR CYTOGENETIC TECHNIQUES | 0 | 20% | 2% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
CD248: Reviewing its Role in Health and Disease | 2012 | 7 | 54 | 56% |
Characteristics of human Ewing/PNET sarcoma models | 2011 | 5 | 66 | 26% |
Endosialin: from vascular target to biomarker for human sarcomas | 2009 | 7 | 75 | 27% |
Newer vascular targets: Endosialin (review) | 2007 | 16 | 83 | 11% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOMED RHEUMATOL GRP | 1 | 50% | 1.1% | 1 |
2 | MRC IMMUNE REGULAT MED DENT SCI | 1 | 50% | 1.1% | 1 |
3 | BIOMED CLIN EXPT MED | 0 | 33% | 1.1% | 1 |
4 | VIB VESALIUS VRC | 0 | 33% | 1.1% | 1 |
5 | PENN OVARIAN CANC | 0 | 18% | 2.2% | 2 |
6 | INF 581 | 0 | 25% | 1.1% | 1 |
7 | TRANSLAT MED DIAGNOST | 0 | 25% | 1.1% | 1 |
8 | BIO TECHNOL PROT | 0 | 13% | 2.2% | 2 |
9 | SECT MOL HEPATOL ALCOHOL ASSOCIATED DIS | 0 | 14% | 1.1% | 1 |
10 | TRANSGEN MOUSE MODELS | 0 | 13% | 1.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000186149 | ANTIANGIOGENIC CANCER VACCINE//CELL PROTEOMIC FOOTPRINTING//HER1 VACCINE |
2 | 0.0000146967 | VASCULOGENIC MIMICRY//TIANJIN CANC HOSP//TEM7 |
3 | 0.0000146683 | PERICYTES//PERICYTE//BOVINE RETINAL PERICYTES |
4 | 0.0000096089 | JEFFERSON STEM CELL BIOL REGENERAT MED//CANCER ASSOCIATED FIBROBLASTS//CANCER ASSOCIATED FIBROBLAST |
5 | 0.0000095526 | COMP RUCT TECHNOL SERV//HOUSEHOLDER REDUCTION//COCKRELL FAMILY REGENTS CHAIR ENGN |
6 | 0.0000092972 | CDCP1//TRASK//SUBTRACTIVE IMMUNIZATION |
7 | 0.0000076924 | SECRETOME//90K MAC 2BP//90K |
8 | 0.0000072895 | THROMBOMODULIN//SOLUBLE THROMBOMODULIN//PLASMA THROMBOMODULIN |
9 | 0.0000070556 | PHARMACEUT PROTE//PRE LIGAND BINDING ASSEMBLY DOMAIN PLAD//TUMOR NECROSIS FACTOR RECEPTOR TNFR |
10 | 0.0000069977 | IMMUNOCYTOKINES//IMMUNOCYTOKINE//PHILOCHEM AG |